These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17060560)

  • 1. Relationship of vascular risk to the progression of Alzheimer disease.
    Regan C; Katona C; Walker Z; Hooper J; Donovan J; Livingston G
    Neurology; 2006 Oct; 67(8):1357-62. PubMed ID: 17060560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alteration of a clinically meaningful outcome in the natural history of Alzheimer's disease by cholinesterase inhibition.
    Lopez OL; Becker JT; Saxton J; Sweet RA; Klunk W; DeKosky ST
    J Am Geriatr Soc; 2005 Jan; 53(1):83-7. PubMed ID: 15667381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors.
    Roselli F; Tartaglione B; Federico F; Lepore V; Defazio G; Livrea P
    Clin Neurol Neurosurg; 2009 May; 111(4):327-30. PubMed ID: 19036496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymptomatic spontaneous cerebral emboli predict cognitive and functional decline in dementia.
    Purandare N; Voshaar RC; Morris J; Byrne JE; Wren J; Heller RF; McCollum CN; Burns A
    Biol Psychiatry; 2007 Aug; 62(4):339-44. PubMed ID: 17531959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease.
    Deschaintre Y; Richard F; Leys D; Pasquier F
    Neurology; 2009 Sep; 73(9):674-80. PubMed ID: 19720973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of exercise and other risk factors to depression of Alzheimer's disease: the LASER-AD study.
    Regan C; Katona C; Walker Z; Livingston G
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):261-8. PubMed ID: 15717340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study.
    Rockwood K; Moorhouse PK; Song X; MacKnight C; Gauthier S; Kertesz A; Montgomery P; Black S; Hogan DB; Guzman A; Bouchard R; Feldman H;
    J Neurol Sci; 2007 Jan; 252(2):106-12. PubMed ID: 17189642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Vascular factors and progression of cognitive decline in elderly people].
    Bidzan L; Bidzan M
    Psychiatr Pol; 2005; 39(5):987-95. PubMed ID: 16358597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.
    Knopman DS; Mosley TH; Catellier DJ; Coker LH;
    Alzheimers Dement; 2009 May; 5(3):207-14. PubMed ID: 19362884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular risk aggravates the progression of Alzheimer's disease in a Chinese cohort.
    Li J; Zhang M; Xu ZQ; Gao CY; Fang CQ; Deng J; Yan JC; Wang YJ; Zhou HD
    J Alzheimers Dis; 2010; 20(2):491-500. PubMed ID: 20164563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil preserves cognition and global function in patients with severe Alzheimer disease.
    Black SE; Doody R; Li H; McRae T; Jambor KM; Xu Y; Sun Y; Perdomo CA; Richardson S
    Neurology; 2007 Jul; 69(5):459-69. PubMed ID: 17664405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
    Squitti R; Bressi F; Pasqualetti P; Bonomini C; Ghidoni R; Binetti G; Cassetta E; Moffa F; Ventriglia M; Vernieri F; Rossini PM
    Neurology; 2009 Jan; 72(1):50-5. PubMed ID: 19122030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients.
    Behl P; Bocti C; Swartz RH; Gao F; Sahlas DJ; Lanctot KL; Streiner DL; Black SE
    Arch Neurol; 2007 Feb; 64(2):266-72. PubMed ID: 17296844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loneliness and risk of Alzheimer disease.
    Wilson RS; Krueger KR; Arnold SE; Schneider JA; Kelly JF; Barnes LL; Tang Y; Bennett DA
    Arch Gen Psychiatry; 2007 Feb; 64(2):234-40. PubMed ID: 17283291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral white matter changes and rate of progression of dementia during cholinesterase inhibitor treatment: a retrospective cohort study.
    Devine ME; Fonseca JA; Walker RW; Sikdar T; Stevens T; Walker Z
    Int J Geriatr Psychiatry; 2007 Nov; 22(11):1120-6. PubMed ID: 17457951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of cognitive activity to risk of developing Alzheimer disease.
    Wilson RS; Scherr PA; Schneider JA; Tang Y; Bennett DA
    Neurology; 2007 Nov; 69(20):1911-20. PubMed ID: 17596582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity in risk factors for cognitive impairment, no dementia: population-based longitudinal study from the Kungsholmen Project.
    Monastero R; Palmer K; Qiu C; Winblad B; Fratiglioni L
    Am J Geriatr Psychiatry; 2007 Jan; 15(1):60-9. PubMed ID: 17194816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the slopes of cognitive impairment and disability in Alzheimer's disease (AD) patients treated with acetylcholinesterase inhibitors (AChEl).
    Campanozzi MD; Casali E; Neviani F; Martini E; Neri M
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():91-6. PubMed ID: 17317439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.